Asparaginase Escherichia coli-derived - Kyowa Kirin
Alternative Names: LeunaseLatest Information Update: 16 Jan 2022
Price :
$50 *
At a glance
- Originator Kyowa Hakko Kirin
- Developer Kyowa Kirin
- Class Amidohydrolases; Antineoplastics
- Mechanism of Action Asparagine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 30 Apr 2013 Registered for Acute lymphoblastic leukaemia in Japan (IM)
- 30 Apr 2013 Registered for Lymphoma in Japan (IM)
- 04 Oct 2012 Preregistration for Acute lymphoblastic leukaemia in Japan (IM)